Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase 1 2Phase NA 1Phase 4 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 401Neoplasms 343Prostatic Neoplasms 193Lung Neoplasms 178Colorectal Neoplasms 145Motor Activity 92Pancreatic Neoplasms 73Brain Neoplasms 73Uterine Cervical Neoplasms 72Head and Neck Neoplasms 68Carcinoma, Non-Small-Cell Lung 64Ovarian Neoplasms 61Carcinoma, Hepatocellular 53Rectal Neoplasms 50Colonic Neoplasms 46Glioblastoma 44Anxiety Disorders 43Depression 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Neoplasm Metastasis 40Hematologic Neoplasms 38Melanoma 36Glioma 34Disease 34Multiple Myeloma 33Stomach Neoplasms 32Sarcoma 32Carcinoma, Renal Cell 31Urinary Bladder Neoplasms 30Pain 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neurofibroma, Plexiform × 90 days × Clear all
NCT06507748 2026-06-05

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

National Institutes of Health Clinical Center (CC)

Phase NA Recruiting
70 enrolled
CNS

Neurofibromatosis 1, Pain, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡